US 8779151
Orally bioavailable caffeic acid related anticancer drugs
granted A61PA61P1/00A61P1/02
Quick answer
US patent 8779151 (Orally bioavailable caffeic acid related anticancer drugs) held by The Board of Regents of the University of Texas System expires Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16